Just 24 Minutes of Music May Offer Significant Anxiety Relief, Modern Research Suggests
Anxiety disorders are a pervasive global health concern, impacting millions and often presenting significant barriers to treatment. Traditional approaches, such as medication and cognitive behavioral therapy (CBT), can be effective but are often hampered by factors like cost, accessibility, and potential side effects. Now, a promising new avenue for anxiety management is emerging: specially designed music paired with auditory beat stimulation (ABS). A recent randomized clinical trial conducted by researchers at Toronto Metropolitan University (TMU) has revealed that just 24 minutes of this therapeutic combination can significantly reduce both the cognitive and physical symptoms of anxiety, offering a potentially accessible and drug-free option for those seeking relief.
The study, published January 21, 2026, in PLOS Mental Health, investigated the “dose-response” relationship between music, ABS, and anxiety reduction. Researchers found that even as various listening durations showed positive effects, a 24-minute session consistently delivered the most substantial benefits. This suggests there may be an optimal “sweet spot” for therapeutic music, providing meaningful anxiety reduction without requiring extensive time commitments. The findings are particularly encouraging given the growing demand for accessible mental health solutions and the limitations of conventional treatments.
The clinical trial, a collaboration between TMU psychology researchers Danielle K. Mullen and Frank A. Russo and the digital therapeutics company LUCID, involved 144 adults experiencing moderate trait anxiety. Participants, who were already receiving medication for their anxiety, were randomly assigned to one of four listening conditions: pink noise (a control), music with ABS at 12 minutes, music with ABS at 24 minutes, or music with ABS at 36 minutes. Before and after each session, participants completed standardized assessments to measure their anxiety levels and mood. The results consistently demonstrated that music with ABS reliably reduced both cognitive and somatic symptoms of anxiety compared to the pink noise control group.
How Does Auditory Beat Stimulation Work?
Auditory beat stimulation (ABS) is a technique that utilizes rhythmic sound patterns to influence brain activity. It works by presenting slightly different frequencies of sound to each ear. The brain then perceives a third, pulsating tone – the “beat” – which can entrain brainwave activity. Researchers believe this entrainment can promote relaxation and reduce anxiety by influencing neural oscillations associated with emotional regulation. While the precise mechanisms are still being investigated, ABS has shown promise in various applications, including sleep enhancement and pain management. The combination of carefully composed music and ABS appears to amplify these effects, creating a synergistic therapeutic experience.
The Study’s Key Findings: A 24-Minute “Sweet Spot”
The study’s most compelling finding was the identification of a 24-minute listening duration as the most effective for anxiety reduction. While both the 24-minute and 36-minute sessions yielded comparable results, the 24-minute session outperformed the 12-minute session significantly. “What we’re seeing is a dose-response pattern where about 24 minutes of music with ABS seems to be the sweet spot,” explained Professor Russo, also Chief Science Officer at LUCID. “It’s long enough to meaningfully shift anxiety levels, but not so long that listeners necessitate to carve out a large block of time.” ScienceDaily reported on the findings, highlighting the potential for a quick and accessible anxiety management tool.
The researchers used standardized measures to assess anxiety levels, focusing on both cognitive symptoms – such as worry and racing thoughts – and somatic symptoms – like muscle tension and increased heart rate. Participants in the music with ABS groups reported significant improvements in both areas, as well as a reduction in negative mood. This suggests that the intervention addresses a broad range of anxiety manifestations, offering a holistic approach to symptom management. The study’s design, a randomized controlled trial, strengthens the validity of its findings, minimizing the risk of bias and providing robust evidence for the effectiveness of the intervention.
Music-Based Digital Therapeutics: A Growing Field
The emergence of music-based digital therapeutics represents a significant shift in the landscape of mental healthcare. These tools leverage the power of music, often combined with technologies like ABS, to deliver personalized and accessible interventions. Unlike traditional treatments, digital therapeutics can be readily accessed via smartphones or computers, eliminating geographical barriers and reducing wait times. They also offer a cost-effective alternative to expensive therapy sessions or medication.
LUCID, the digital therapeutics company involved in the TMU study, is at the forefront of this innovation. Founded as a spin-off from TMU’s Zone Learning ecosystem, LUCID is dedicated to developing evidence-based digital solutions for mental health challenges. The company’s approach focuses on creating engaging and personalized listening experiences that are tailored to individual needs and preferences. The success of the TMU clinical trial underscores the potential of this approach to transform anxiety management and improve the lives of millions.
The Prevalence of Anxiety and the Need for Accessible Solutions
Anxiety disorders are among the most common mental health conditions worldwide. According to the World Health Organization, an estimated 301 million people globally suffer from anxiety disorders. These conditions can significantly impair daily functioning, affecting relationships, work, and overall quality of life. Despite the high prevalence, access to effective treatment remains limited due to factors such as cost, stigma, and a shortage of qualified mental health professionals. This creates a critical need for innovative and accessible solutions like music-based digital therapeutics.
The COVID-19 pandemic has further exacerbated the global mental health crisis, with rates of anxiety and depression soaring. Lockdowns, social isolation, and economic uncertainty have contributed to increased stress and anxiety levels, highlighting the urgent need for scalable and effective mental health interventions. Digital therapeutics offer a promising solution, providing individuals with readily available tools to manage their anxiety and promote emotional well-being.
What’s Next for Music and Anxiety Research?
While the TMU study provides compelling evidence for the effectiveness of music with ABS in reducing anxiety, further research is needed to refine the intervention and explore its potential applications. Future studies could investigate the optimal musical characteristics for anxiety reduction, such as tempo, melody, and instrumentation. Researchers are also exploring the potential of personalized music interventions, tailoring the music to individual preferences and brainwave patterns. Studies are underway to examine the long-term effects of music with ABS and its potential to prevent the development of chronic anxiety disorders.
The team at TMU and LUCID are continuing their research, with plans to conduct larger-scale clinical trials and explore the use of music with ABS in other populations, such as individuals with post-traumatic stress disorder (PTSD) and chronic pain. They are also working to develop a user-friendly digital platform that will make this therapeutic intervention accessible to a wider audience. The next phase of research will focus on understanding the neurobiological mechanisms underlying the effects of music with ABS, providing further insights into how this intervention can effectively modulate brain activity and reduce anxiety.
The findings from this research offer a beacon of hope for individuals struggling with anxiety, suggesting that a simple, accessible, and drug-free intervention may be within reach. As research continues and digital therapeutics become more widely adopted, the future of anxiety management looks increasingly promising.
Researchers will continue to analyze data from the clinical trial and plan to publish further findings in the coming months. Updates on the research and the development of the digital platform will be available on the LUCID Therapeutics website. For those interested in learning more about anxiety and mental health resources, the National Institute of Mental Health (NIMH) provides comprehensive information and support.
What are your thoughts on using music as a therapeutic tool? Share your experiences and perspectives in the comments below. And if you found this article helpful, please share it with your network.
Worth a look